Bicycle Therapeutics Plc2024财年第三财季实现净利润-51.32百万美元，同比减少3.45%

市场透视11-09

11月9日，Bicycle Therapeutics Plc（BCYC.US）公布财报，公告显示公司2024财年第三财季净利润为-51.32百万美元，同比减少3.45%；其中营业收入为2.70百万美元，同比减少49.25%，每股基本收益为-0.74美元。从资产负债表来看，Bicycle Therapeutics Plc（BCYC.US）总负债1.66亿美元，其中短期债务5.55百万美元，资产负债...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2482990485?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-09 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2482990485","market":"us","top_or_hot":-1,"title":"Bicycle Therapeutics Plc2024财年第三财季实现净利润-51.32百万美元，同比减少3.45%","media":"市场透视","content":"<div>\n<p>11月9日，Bicycle Therapeutics Plc（BCYC.US）公布财报，公告显示公司2024财年第三财季净利润为-51.32百万美元，同比减少3.45%；其中营业收入为2.70百万美元，同比减少49.25%，每股基本收益为-0.74美元。从资产负债表来看，Bicycle Therapeutics Plc（BCYC.US）总负债1.66亿美元，其中短期债务5.55百万美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000039a224f54d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bicycle Therapeutics Plc2024财年第三财季实现净利润-51.32百万美元，同比减少3.45%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBicycle Therapeutics Plc2024财年第三财季实现净利润-51.32百万美元，同比减少3.45%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-09 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000039a224f54d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月9日，Bicycle Therapeutics Plc（BCYC.US）公布财报，公告显示公司2024财年第三财季净利润为-51.32百万美元，同比减少3.45%；其中营业收入为2.70百万美元，同比减少49.25%，每股基本收益为-0.74美元。从资产负债表来看，Bicycle Therapeutics Plc（BCYC.US）总负债1.66亿美元，其中短期债务5.55百万美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000039a224f54d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000039a224f54d&s=b","article_id":"2482990485","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000039a224f54d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2482990485","pubTimestamp":1731081622,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月9日，Bicycle Therapeutics Plc公布财报，公告显示公司2024财年第三财季净利润为-51.32百万美元，同比减少3.45%；其中营业收入为2.70百万美元，同比减少49.25%，每股基本收益为-0.74美元。从资产负债表来看，Bicycle Therapeutics Plc总负债1.66亿美元，其中短期债务5.55百万美元，资产负债比为6.01，流动比率为0.18。机构评级：截至2024年11月9日，当前有13家机构对Bicycle Therapeutics Plc目标价做出预测，其中目标均价为37.77美元，其中最低目标价为25.00美元，最高目标价为55.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BCYC":"Bicycle Therapeutics Limited"},"translate_title":"Bicycle Therapeutics Plc achieved net profit of-US $51.32 million in the third fiscal quarter of fiscal year 2024, a year-on-year decrease of 3.45%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"BCYC":0.9},"content_text":"11月9日，Bicycle Therapeutics Plc（BCYC.US）公布财报，公告显示公司2024财年第三财季净利润为-51.32百万美元，同比减少3.45%；其中营业收入为2.70百万美元，同比减少49.25%，每股基本收益为-0.74美元。从资产负债表来看，Bicycle Therapeutics Plc（BCYC.US）总负债1.66亿美元，其中短期债务5.55百万美元，资产负债比为6.01，流动比率为0.18。机构评级：截至2024年11月9日，当前有13家机构对Bicycle Therapeutics Plc目标价做出预测，其中目标均价为37.77美元，其中最低目标价为25.00美元，最高目标价为55.00美元。公司简介：Bicycle Therapeutics PLC是一家临床阶段的生物制药公司，开发一种被称为Bicycles的新型药物。 Bicycles是合成的短肽，被限制成两个环，以稳定其几何结构。 它最初的内部计划主要针对具有高度未被满足医疗需求的肿瘤学适应症。 该公司的候选产品BT1718是一种Bicycle 毒素结合物（BTC）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482990485"}